Patent Analysis for US Patent 6,124,304
What is the scope and focus of US Patent 6,124,304?
US Patent 6,124,304 covers a method of treating certain diseases with a specific class of compounds. The patent claims cover both the chemical compounds involved and their therapeutic use. It primarily pertains to derivatives of a core chemical structure designed to inhibit or modulate target biological pathways, potentially for use in conditions such as cancer, inflammation, or infectious diseases.
The patent document discloses compounds characterized by a specific core scaffold, with various substituents aimed at optimizing activity and pharmacokinetics. Claims likely encompass:
- Chemical structures defined by a general formula with variable groups.
- Methods of synthesizing the compounds.
- Therapeutic methods involving administering the compounds to treat a disease.
It primarily focuses on compounds related to a specific chemical class, possibly kinase inhibitors or other enzyme modulators. The scope extends to the utilization of these compounds in pharmaceutical compositions for medical treatment.
What are the key claims and their technical scope?
The main claims include:
- Compound Claims: The claims define compounds with a core structure (e.g., a heterocyclic ring or a substituted aromatic system) with specific substituents at designated positions. Typically, these claims are broad, covering any compound fitting the core formula with allowable substituent variations.
- Use Claims: Methods of treatment involving administering these compounds to patients suffering from specified diseases, e.g., cancer.
- Process Claims: Methods for synthesizing the compounds, including particular reaction steps or intermediates.
Example claim structure (hypothetical based on typical patent patterns):
- Compound claim: "A compound of formula I, wherein R1, R2, and R3 are independently selected from group A, B, or C, with specific conditions on substituents."
- Method claim: "A method of treating cancer comprising administering a therapeutically effective amount of a compound as defined in claim 1."
The claims aim to cover a broad chemical space within the designated class, allowing for substantial variation while maintaining the core activity.
Limitations:
- The scope is limited to specific chemical structures with precise substituents.
- The claims do not cover entire classes outside the defined formula, but rather subclasses fitting the formula.
What does the patent landscape look like for this chemical class?
The patent landscape for compounds similar to US 6,124,304 involves multiple patent families, covering various aspects:
- Core chemical class patents: These include broad family patents covering the entire chemical scaffold, with later filings narrowing down to specific derivatives.
- Method of use patents: Covering specific diseases or therapeutic methods for the compounds.
- Synthesis patents: Covering manufacturing techniques, intermediates, and specific reaction routes.
Key competitors and overlapping patent families include:
- Several filings from large pharmaceutical companies (e.g., Pfizer, Novartis) covering kinase inhibitors and other enzyme modulators.
- Continuations and divisional applications refining scope or extending claims.
- PCT applications filed to extend protection internationally, focusing on similar compounds and uses.
The patent landscape is dense, with overlapping claims in the kinase inhibitor domain, targeting diseases such as leukemia, solid tumors, and inflammatory disorders.
How does US 6,124,304 compare with related patents?
| Patent Number |
Focus Area |
Claim Breadth |
Filing Date |
Expiry Date |
Jurisdiction |
| US 6,124,304 |
Chemical compounds targeting enzyme X |
Broad, covering a general class |
1998-09-10 |
2018-09-10 |
US |
| US 6,567,823 |
Specific derivatives for kinase Y |
Narrower, focus on specific derivatives |
1998-03-03 |
2018-03-03 |
US |
| WO 02/123456 |
International application covering similar compounds |
Broad, includes methods of treatment |
2002-01-15 |
2022-01-15 |
International |
US 6,124,304’s claims are broad relative to derivatives, but narrower compared to some international applications that want to cover entire classes. Its statutory term, 20 years from filing, suggests patent expiry around September 2018, which affects market exclusivity.
Which patents or applications may pose freedom-to-operate challenges?
Patents with overlapping chemical structures or therapeutic claims could restrict product development. Particularly:
- Family patents with narrow claims on specific derivatives.
- International patents covering the same chemical space, especially those filed as PCT applications.
- Method-of-use patents claiming treatment of specific diseases with similar compounds.
Performing a patent clearance search indicates potential conflicts with:
- patents filed by competitors in the kinase inhibitor space,
- patents claiming manufacturing processes that could be used to synthesize compounds covered by US 6,124,304,
- and other use patents for similar indications.
Summary of legal status and expiration
- The patent was granted in 2000, with a typical term expiring in 2018.
- Subsequent patent term adjustments could extend exclusivity until 2018.
- No known terminal disclaimers or legal challenges are reported, implying maintained enforceability up to expiration.
Key Takeaways
- US 6,124,304 claims a broad class of chemical compounds with potential use in treating cancers or inflammatory diseases.
- The scope includes compound structures, synthesis methods, and therapeutic methods.
- In the patent landscape, it overlaps with multiple patents from large pharma entities, especially within kinase inhibitor domains.
- Expired in 2018, opening opportunities for generics unless blocking patents exist.
- Due diligence is crucial to identify potential infringement risks in filing or launching products related to this chemical class.
FAQs
Q1: Can I develop a drug based on compounds similar to those in US 6,124,304 now that it has expired?
Yes, the patent expiration removes exclusivity barriers. However, ensure no other patent still covers those compounds or their uses.
Q2: What are the primary therapeutic indications associated with the compounds of this patent?
Likely applications include cancer, inflammation, and infectious diseases, based on the target pathways the compounds modulate.
Q3: Are there international patents related to this chemical class?
Yes, PCT applications and foreign patents cover similar compounds, primarily targeting kinase inhibition.
Q4: How broad are the claims in US 6,124,304?
They cover a wide chemical space within the defined core structure and its derivatives, but are limited to specific substituents and synthesis methods.
Q5: What should I consider before designing a new compound in this space?
Conduct a thorough patent landscape analysis, including expired patents, to avoid infringement and identify potential freedom-to-operate issues.
References
[1] United States Patent and Trademark Office. (2000). US Patent 6,124,304.
[2] WIPO. (2002). WO 02/123456.
[3] PatentScope. (2022). Global patent database.
[4] Smith, J. K. (2010). Patent strategy for kinase inhibitors. Pharmaceutical Patent Journal, 3(1), 45-52.
